1. Home
  2. KRYS vs MUR Comparison

KRYS vs MUR Comparison

Compare KRYS & MUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KRYS
  • MUR
  • Stock Information
  • Founded
  • KRYS 2015
  • MUR 1950
  • Country
  • KRYS United States
  • MUR United States
  • Employees
  • KRYS N/A
  • MUR N/A
  • Industry
  • KRYS Biotechnology: Biological Products (No Diagnostic Substances)
  • MUR Oil & Gas Production
  • Sector
  • KRYS Health Care
  • MUR Energy
  • Exchange
  • KRYS Nasdaq
  • MUR Nasdaq
  • Market Cap
  • KRYS 4.7B
  • MUR 4.1B
  • IPO Year
  • KRYS 2017
  • MUR N/A
  • Fundamental
  • Price
  • KRYS $196.65
  • MUR $28.55
  • Analyst Decision
  • KRYS Strong Buy
  • MUR Hold
  • Analyst Count
  • KRYS 9
  • MUR 15
  • Target Price
  • KRYS $214.22
  • MUR $27.38
  • AVG Volume (30 Days)
  • KRYS 316.5K
  • MUR 1.9M
  • Earning Date
  • KRYS 11-03-2025
  • MUR 11-05-2025
  • Dividend Yield
  • KRYS N/A
  • MUR 4.57%
  • EPS Growth
  • KRYS 275.72
  • MUR N/A
  • EPS
  • KRYS 6.66
  • MUR 0.99
  • Revenue
  • KRYS $373,164,000.00
  • MUR $2,746,335,000.00
  • Revenue This Year
  • KRYS $34.33
  • MUR N/A
  • Revenue Next Year
  • KRYS $48.04
  • MUR $2.57
  • P/E Ratio
  • KRYS $29.71
  • MUR $28.67
  • Revenue Growth
  • KRYS 54.51
  • MUR N/A
  • 52 Week Low
  • KRYS $122.80
  • MUR $18.95
  • 52 Week High
  • KRYS $212.98
  • MUR $34.52
  • Technical
  • Relative Strength Index (RSI)
  • KRYS 59.19
  • MUR 53.70
  • Support Level
  • KRYS $194.92
  • MUR $26.49
  • Resistance Level
  • KRYS $212.98
  • MUR $28.79
  • Average True Range (ATR)
  • KRYS 8.35
  • MUR 0.97
  • MACD
  • KRYS -0.17
  • MUR -0.08
  • Stochastic Oscillator
  • KRYS 42.14
  • MUR 60.03

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About MUR Murphy Oil Corporation

Murphy Oil Corp is an oil and gas exploration and production company, with both onshore and offshore operations and properties. It operates in two geographic reportable segments the United States and Canada. It generates the majority of its revenue form the United States.

Share on Social Networks: